Skip to main content
CRBU
NASDAQ Life Sciences

Caribou 10-Q: $94.8M Cash, $26.6M Q3 Loss, Nasdaq Bid-Price Deficiency Disclosed

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$0.405
Mkt Cap
$44.202M
52W Low
$0.403
52W High
$2.49
52W Position info
0.5% above low
Off High info
84% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CRBU is trading near its 52-week low of $0.403 (0.5% above the low).

Summary

Caribou's Q3 10-Q shows $94.8M in cash against a $26.6M quarterly loss and $15.0M-$19.0M of restructuring charges still ahead, while disclosing the stock has sat below Nasdaq's $1.00 minimum bid since the October strategic-alternatives announcement.


Key Events · Earnings and Guidance · CRBU

  • Q3 Loss of $26.6M, Cash Down to $94.8M

    GAAP net loss was $26.6 million ($0.25 per share) versus $27.5 million ($0.30) a year earlier; cash, equivalents and marketable securities fell to $94.8 million from $142.8 million at December 31, 2025.

  • Restructuring to Cost $15M-$19M

    The October 2026 restructuring — severance of $10.0M-$11.0M plus $5.0M-$8.0M to wind down the ANTLER and CaMMouflage trials — is mostly unrecognized and expected in Q4 2026, so it is not in the Q3 figures.

  • Nasdaq $1.00 Bid-Price Deficiency

    The 10-Q states the stock has consistently traded below Nasdaq's $1.00 minimum bid since the October 6, 2026 announcement, and that a reverse split may be needed; delisting would push the shares under penny-stock rules.

  • ATM Was the Only New Capital

    Caribou sold 11,565,913 shares in the first nine months at an average $2.01 for $23.3 million gross ($22.8 million net), including 1,480,869 shares at $1.84 for $2.7 million in Q3; $72.5 million remains available under the program.


Analysis · CRBU · Life Sciences

The Q3 numbers were already out via this morning's 8-K, but the full 10-Q carries two things the press release did not. First, the cash math: $94.8M at September 30 against $72.3M of nine-month operating burn, with $15.0M-$19.0M of restructuring costs still to come, mostly in Q4 — the runway is real but shrinking fast while the board shops for a merger, sale or liquidation. Second, the company now says its stock has traded consistently below Nasdaq's $1.00 minimum bid since the October 6 announcement, which puts a delisting clock and a possible reverse split on the table. The ATM was the only source of new money: 11.6M shares sold for $23.3M gross in the first nine months, at average prices far above today's $0.405, and $72.5M remains available on the program.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CRBU was trading at $0.41 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $44.2M. The 52-week trading range was $0.40 to $2.49. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CRBU - Latest Insights

CRBU
Nov 05, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.405
Real-time Price: $0.3199 info
Change: -$0.0851 (-21%) info
Market Cap: $33.545M info
CRBU
Oct 06, 2026, 4:37 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.705
Real-time Price: $0.3199 info
Change: -$0.3851 (-55%) info
Market Cap: $33.545M info
CRBU
Oct 06, 2026, 4:11 PM EDT
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $1.14
Real-time Price: $0.3199 info
Change: -$0.8151 (-72%) info
Market Cap: $33.545M info
CRBU
Oct 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.14
Real-time Price: $0.3199 info
Change: -$0.8151 (-72%) info
Market Cap: $33.545M info
CRBU
Aug 13, 2026, 4:11 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $1.61
Real-time Price: $0.3199 info
Change: -$1.29 (-80%) info
Market Cap: $33.545M info